Skip to main content
. 2021 Nov 18;148(1):70–79. doi: 10.1001/jamaoto.2021.3228

Figure 3. Immune Transcript Landscape of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) and Cervical Squamous Cell Carcinoma (CESC) by Anatomical Site.

Figure 3.

The reduced visualization is based on 2630 immune-related transcripts in patients with HNSCC and CESC, produced by TumorMap33 and representing the global landscape across all sites (upper left); oropharyngeal squamous cell carcinoma (OPSCC), nonoropharyngeal (non-OP) HNSCC, and CESC (upper right); and non-OP HNSCC split into hypopharyngeal squamous cell carcinoma (HPSCC), laryngeal squamous cell carcinoma (LSCC), and oral cavity squamous cell carcinoma (OCSCC) (lower right). Separation percentages represent the proportion of human papillomavirus (HPV)–positive patients quantitatively separated from HPV-negative patients.